Association Between the Neutrophil Percentage-to-Albumin Ratio and Outcomes in Cardiac Intensive Care Unit Patients

References

• Bowry ADK, Lewey J, Dugani SB, et al. The burden of cardiovascular disease in low- and middle-income countries: epidemiology and management. The Canadian Journal of Cardiology. 2015;31(9):1151–1159. doi:10.1016/j.cjca.2015.06.028
   PubMed Web of Science ®Google Scholar
• Sun H. The neutrophil-lymphocyte ratio: a promising predictor of mortality in coronary care unit patients - a cohort study. International Immunopharmacology. 2019;74:105692. doi:10.1016/j.intimp.2019.105692
   PubMed Web of Science ®Google Scholar
• Steven S, Frenis K, Oelze M, et al. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7092151. doi:10.1155/2019/7092151
   PubMed Web of Science ®Google Scholar
• Hartaigh B, Bosch JA, Thomas GN, et al. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis. 2012;224(1):161–169. doi:10.1016/j.atherosclerosis.2012.04.012
   PubMed Web of Science ®Google Scholar
• Eckart A, Struja T, Kutz A, et al. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. The American Journal of Medicine. 2020;133(6):713–722.e7. doi:10.1016/j.amjmed.2019.10.031
   PubMed Web of Science ®Google Scholar
• Jensen GL, Mirtallo J, Compher C, et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral Nutr. 2010;34(2):156–159. doi:10.1177/0148607110361910
   PubMed Web of Science ®Google Scholar
• Gehring N. Serumalbumin–a qualified parameter to determine the nutritional status? Swiss Med Wkly. 2006;136(41–42):664–669.
   PubMed Web of Science ®Google Scholar
• Tingle SJ, Severs GR, Goodfellow M, et al. NARCA: a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. Journal of Surgical Oncology. 2018;118(4):680–686. doi:10.1002/jso.25209
   PubMed Web of Science ®Google Scholar
• Wang B. The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute kidney injury. Biomed Res Int. 2020;2020:5687672.
   PubMed Web of Science ®Google Scholar
• Gong Y. Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiology and Infection. 2020;148:e87.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–1565. doi:10.1056/NEJMoa021993
   PubMed Web of Science ®Google Scholar
• Osman R, L’Allier PL, Elgharib N, et al. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006;2(3):221–237. doi:10.2147/vhrm.2006.2.3.221
   PubMedGoogle Scholar
• Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035. doi:10.1038/sdata.2016.35
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963. doi:10.1001/jama.1993.03510240069035
   PubMed Web of Science ®Google Scholar
• Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nature Medicine. 2011;17(11):1410–1422. doi:10.1038/nm.2538
   PubMed Web of Science ®Google Scholar
• Tuñón J, Badimón L, Bochaton-Piallat M-L, et al. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology. Cardiovasc Res. 2019;115(1):10–19. doi:10.1093/cvr/cvy293
   PubMed Web of Science ®Google Scholar
• Lutgens E, Atzler D, Döring Y, et al. Immunotherapy for cardiovascular disease. Eur Heart J. 2019;40(48):3937–3946. doi:10.1093/eurheartj/ehz283
   PubMed Web of Science ®Google Scholar
• Adamsson Eryd S, Smith JG, Melander O, et al. Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts. Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32(2):533–539. doi:10.1161/ATVBAHA.111.240416
   PubMed Web of Science ®Google Scholar
• Pfister R, Tuñón J, Badimón L, et al. Differential white blood cell count and incident heart failure in men and women in the EPIC-Norfolk study. Eur Heart J. 2012;33(4):523–530. doi:10.1093/eurheartj/ehr457
   PubMed Web of Science ®Google Scholar
• Zia E, Melander O, Björkbacka H, et al. Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study. Journal of Internal Medicine. 2012;272(3):298–304. doi:10.1111/j.1365-2796.2012.02526.x
   PubMed Web of Science ®Google Scholar
• Dragu R, Huri S, Zukermann R, et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2008;196(1):405–412. doi:10.1016/j.atherosclerosis.2006.11.022
   PubMed Web of Science ®Google Scholar
• Shah AD, Denaxas S, Nicholas O, et al. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER cohort study. J Am Coll Cardiol. 2017;69(9):1160–1169. doi:10.1016/j.jacc.2016.12.022
   PubMed Web of Science ®Google Scholar
• Wheeler J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J. 2004;25(15):1287–1292.
   PubMed Web of Science ®Google Scholar
• Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Texas Heart Institute j. 2013;40(1):17–29.
   PubMed Web of Science ®Google Scholar
• Roche M. The antioxidant properties of serum albumin. FEBS Letters. 2008;582(13):1783–1787. doi:10.1016/j.febslet.2008.04.057
   PubMed Web of Science ®Google Scholar
• Caraceni P. Clinical indications for the albumin use: still a controversial issue. European Journal of Internal Medicine. 2013;24(8):721–728. doi:10.1016/j.ejim.2013.05.015
   PubMed Web of Science ®Google Scholar
• Kitano H. Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading. Alcohol Clin Exp Res. 1996;20(1 Suppl):73A–76A.
   PubMed Web of Science ®Google Scholar
• Chen T-A, Tsao Y-C, Chen A, et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44(5):619–625. doi:10.1080/00365520902719273
   PubMed Web of Science ®Google Scholar
• Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. International Journal of General Medicine. 2016;9:229–255. doi:10.2147/IJGM.S102819
   PubMed Web of Science ®Google Scholar
• Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 1997;52(3):761–770. doi:10.1038/ki.1997.393
   PubMed Web of Science ®Google Scholar
• González-Pacheco H, Amezcua-Guerra LM, Sandoval J, et al. Prognostic implications of serum albumin levels in patients with acute coronary syndromes. Am J Cardiol. 2017;119(7):951–958. doi:10.1016/j.amjcard.2016.11.054
   PubMed Web of Science ®Google Scholar
• Chan B, Dodsworth N, Woodrow J, et al. Site-specific N-terminal auto-degradation of human serum albumin. European Journal of Biochemistry. 1995;227(1–2):524–528. doi:10.1111/j.1432-1033.1995.tb20419.x
   PubMedGoogle Scholar
• Thiele H, Allam B, Chatellier G, et al. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J. 2010;31(15):1828–1835. doi:10.1093/eurheartj/ehq220
   PubMed Web of Science ®Google Scholar
• Selejan S-R, Pöss J, Hewera L, et al. Role of receptor for advanced glycation end products in cardiogenic shock. Crit Care Med. 2012;40(5):1513–1522. doi:10.1097/CCM.0b013e318241e536
   PubMed Web of Science ®Google Scholar
• Klein A, Wiberg S, Hassager C, et al. Admission leukocyte count is associated with late cardiogenic shock development and all-cause 30-day mortality in patients with st-elevation myocardial infarction. Shock (Augusta, Ga. 2020;53(3):299–306. doi:10.1097/SHK.0000000000001369
   PubMed Web of Science ®Google Scholar
• Jäntti T, Tarvasmäki T, Harjola V-P, et al. Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. PLoS One. 2019;14(5):e0217006. doi:10.1371/journal.pone.0217006
   PubMed Web of Science ®Google Scholar
• Jentzer JC, Bihorac A, Brusca SB, et al. Contemporary management of severe acute kidney injury and refractory cardiorenal syndrome: JACC Council perspectives. J Am Coll Cardiol. 2020;76(9):1084–1101. doi:10.1016/j.jacc.2020.06.070
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ. Effect of acute kidney injury on long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent primary percutaneous coronary intervention in a high-volume tertiary center. Turk Kardiyoloji Dernegi Arsivi. 2020;48(1):1–9.
   PubMed Web of Science ®Google Scholar
• van Diepen S. Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: an analysis from the Critical Care Cardiology Trials Network Registry. Am Heart J. 2020;222:8-14. Doi :10.1016/j.ahj.2020.01.005
   PubMed Web of Science ®Google Scholar
• Keleshian V, Kashani KB, Kompotiatis P, et al. Short, and long-term mortality among cardiac intensive care unit patients started on continuous renal replacement therapy. Journal of Critical Care. 2020;55:64–72. doi:10.1016/j.jcrc.2019.11.001
   PubMed Web of Science ®Google Scholar
• Ridker P, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207. doi:10.1056/NEJMoa0807646
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Pencina M, Jacques P, et al. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008;1(2):92–97. doi:10.1161/CIRCOUTCOMES.108.831198
   PubMed Web of Science ®Google Scholar
• Elkind MSV, Leon V, Moon YP, et al. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A 2 stability before and after stroke and myocardial infarction. Stroke. 2009;40(10):3233–3237. doi:10.1161/STROKEAHA.109.552802
   PubMed Web of Science ®Google Scholar
• Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. International Journal of Epidemiology. 2009;38(1):217–231. doi:10.1093/ije/dyn217
   PubMed Web of Science ®Google Scholar
• Inoue T, Kato T, Uchida T, et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol. 2005;46(2):239–245. doi:10.1016/j.jacc.2005.04.029
   PubMed Web of Science ®Google Scholar